Skip to content
Axcess News – Lifestyle
Author:
CURIS, INC.
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
June 26, 2026
Curis Provides First Quarter 2026 Business Update
May 12, 2026
Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026
May 5, 2026
Curis Provides Fourth Quarter 2025 Business Update
March 19, 2026
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
March 12, 2026